Top 200 Drugs in 2021

Top 200 Pharmaceuticals by Retail Sales in 2021

Compiled and Produced by M. Haziq Qureshi from the Njarðarson Group (The University of Arizona)

Humira (Immunology) which was on top of the list in 2019 with USD 19.723 billions (USD 21.874 Billion in 2021) was overtaken by Comirnaty (COVID-19 Vaccine, mRNA) by Pfizer / Biontech with sales of USD 36.781 Billion in 2021. The COVID-19 Vaccine Spikevax by Moderna arrived 3rd with USD 17.675 Billion in 2021. Orkambi made it to place 200 with USD 772 millions. The poster covers treatments as

  • Immunology
  • Cardiovascular Diseases
  • Oncology
  • Ophthalmology
  • Vaccine
  • Infectious Diseases
  • CNS & Anesthesia
  • Diabetes
  • Hematology
  • Nephrology
  • Gastrointestinal Disorders
  • Respiratory Disorders
  • Genetic Disorders
  • Dermatology
  • Rare Disorders
  • Urology
  • Neurology
  • Miscellaneous

You can download the poster here: Top 200 Drug 2021

TOP 200 DRUGS: As part of our efforts to educate students about how chemistry positively impacts our lives, my research group has created the pharmaceutical posters shown below, which can be downloaded for free as high resolution PDF files from our website. We envisioned that this attractive graphical information would be a useful tool for teaching both undergraduate and graduate students in addition to serving as a spring board of ideas for researchers interested in the development of new synthetic methods and strategies. I hope everyone enjoys these posters as much as we have and I encourage all visitors to download them and use for teaching, fun chemical browsing, research purposes or even as an attractive and accessible graphical summary to help communicate to the public the critical role organic chemistry plays in the development of new medicines. New posters are completed and posted late in April every year. (Please e-mail us any mistakes you come across and we will make sure to correct them promptly). Part of material is based upon work supported by the National Science Foundation under Grants No. 0848324,1266365, 1565500 and now 1857708. Please contact us directly if you need higher resolution PDF files than those presented on this website

J. Chem. Ed. 2010, 87, 1348 when referencing the posters

*Poster information gathered by the Njardarson group with data from DrugTopics & Pharmacompass.

You can download the poster here: Top 200 Drug 2021 or from the University of Arizona website as a free PDF file. If anyone is interested in printing larger size versions, please contact Jon Njardarson and he  will send you a copy of a higher resolution file to print.

You might also like